Heterogeneity of Ki-67 and p53 Expression in Glioblastoma

1. Altman DG, Machin D, Bryant TN, Gardner RJ. Statistics with confidence. 2nd ed. Bristol: BMJ Books; 2000Search in Google Scholar

2. Bhargava R, Beriwal S, Dabbs DJ, Ozbek U, So-ron A, Johnson RR, Brafsky AM, Lembersky BC, Ahrendt GM. Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases // Cancer, 2010; 116:1431 – 1439Search in Google Scholar

3. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index // J Neuropathol Exp Neurol, 1993; 52:609 – 618Search in Google Scholar

4. Dalrymple SJ, Parisi JE, Roche PC, Ziesmer SC, Scheithauer BW, Kelly PJ. Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajec-tory // Neurosurgery, 1994; 35:1036 – 1045Search in Google Scholar

5. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. Astrocytic tumors // Bosman FT, Jaffe ES, Lakhani RS, Ohgaki H. WHO classification of tumours of the central nervous system. 3rd edition. Lyon: IARC, 2007; 13 - 52Search in Google Scholar

6. Milinkovic V, Bankovic J, Rakic M, Milosevic N, Stankovic T, Jokovic M, Milosevic Z, Skender-Gazibara M, Podolski-Renic A, Pesic M, Ruzdijic S, Tanic N. Genomic instability and p53 alterations in patients with malignant glioma // Exp Mol Pathol, 2012; 93:200 - 206Search in Google Scholar

7. Ng K, Kim R, Kesari S, Carter B, Chen CC. Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights // J Neurooncol, 2012; 107:1 - 12Search in Google Scholar

8. Nowell PC. The clonal evolution of tumor cell populations // Science, 1976; 194:23 - 28Search in Google Scholar

9. Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma // Am J Pathol, 2007; 170:1445 - 1453Search in Google Scholar

10. Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors // J Neuropathol Exp Neurol, 2007; 66:944 - 954Search in Google Scholar

11. Soussi T, Lozano G. p53 mutation heterogeneity in cancer // Biochem Biophys Res Commun, 2005; 331:834 - 842Search in Google Scholar

12. Torp SH. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies // Clin Neuropathol, 2002; 21:252 - 257Search in Google Scholar